Trials / Unknown
UnknownNCT03184727
Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The pulmonary vasculopathy and right heart dysfunction in COPD are drawing increasing attention these days. Recent researches show that pulmonary vasculopathy and right heart dysfunction relate to greater severity in COPD. Applying appropriate modalities for early detection of pulmonary vasculopathy and right heart dysfunction is of great importance. What's more, the interaction mechanism between pulmonary vasculature, right heart and COPD still needs to be further studied. The aim of our study is to develop an assessment system of pulmonary vasculopathy and right heart dysfunction in COPD patients and elucidate their impact on COPD course and outcome.
Conditions
Timeline
- Start date
- 2017-06-15
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2017-06-14
- Last updated
- 2017-06-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03184727. Inclusion in this directory is not an endorsement.